Literature DB >> 33928584

Non-covalent Encapsulation of siRNA with Cell-Penetrating Peptides.

Martina Tuttolomondo1, Henrik J Ditzel2,3.   

Abstract

SiRNAs may act as selective and potent therapeutics, but poor deliverability in vivo is a limitation. Among the recently proposed vectors, cell-penetrating peptides (CPPs), also referred as protein transduction domains (PTDs), allow siRNA stabilization and increased cellular uptake. This chapter aims to guide scientists in the preparation and characterization of CPP-siRNA complexes, particularly the evaluation of novel CPPs variants for siRNA encapsulation and delivery. Herein, we present a collection of methods to determine CPP-siRNA interaction, encapsulation, stability, conformation, transfection, and silencing efficiency.

Entities:  

Keywords:  Cell-penetrating peptides; Knockdown; Protein transduction domains; RNA interference; Short interfering RNA; Silencing; Small interfering RNA

Year:  2021        PMID: 33928584     DOI: 10.1007/978-1-0716-1298-9_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  38 in total

1.  Chitosan (CMD)-mediated co-delivery of SN38 and Snail-specific siRNA as a useful anticancer approach against prostate cancer.

Authors:  Amir Afkham; Leili Aghebati-Maleki; Homayoon Siahmansouri; Sanam Sadreddini; Majid Ahmadi; Sanam Dolati; Nahid Manafi Afkham; Parvin Akbarzadeh; Farhad Jadidi-Niaragh; Vahid Younesi; Mehdi Yousefi
Journal:  Pharmacol Rep       Date:  2017-11-20       Impact factor: 3.024

2.  Inhalable siRNA-loaded nano-embedded microparticles engineered using microfluidics and spray drying.

Authors:  Monica Agnoletti; Adam Bohr; Kaushik Thanki; Feng Wan; Xianghui Zeng; Johan Peter Boetker; Mingshi Yang; Camilla Foged
Journal:  Eur J Pharm Biopharm       Date:  2017-08-02       Impact factor: 5.571

3.  siRNA delivery system based on magnetic nanovectors: Characterization and stability evaluation.

Authors:  Mohammed Abdelrahman; Laurence Douziech Eyrolles; Suad Y Alkarib; Katel Hervé-Aubert; Sanaa Ben Djemaa; Hervé Marchais; Igor Chourpa; Stephanie David
Journal:  Eur J Pharm Sci       Date:  2017-06-01       Impact factor: 4.384

Review 4.  Nanoparticles for siRNA-Based Gene Silencing in Tumor Therapy.

Authors:  Anish Babu; Ranganayaki Muralidharan; Narsireddy Amreddy; Meghna Mehta; Anupama Munshi; Rajagopal Ramesh
Journal:  IEEE Trans Nanobioscience       Date:  2016-12       Impact factor: 2.935

Review 5.  siRNA-nanoparticle conjugate in gene silencing: A future cure to deadly diseases?

Authors:  Rituparna Acharya; Suman Saha; Sayantan Ray; Sugata Hazra; Manoj K Mitra; Jui Chakraborty
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2017-03-02       Impact factor: 7.328

6.  Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicine.

Authors:  Kirill A Afonin; Wade W Grabow; Faye M Walker; Eckart Bindewald; Marina A Dobrovolskaia; Bruce A Shapiro; Luc Jaeger
Journal:  Nat Protoc       Date:  2011-12-01       Impact factor: 13.491

Review 7.  Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer.

Authors:  Tamkin Ahmadzada; Glen Reid; David R McKenzie
Journal:  Biophys Rev       Date:  2018-01-11

8.  Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA delivery.

Authors:  Tomohiro Asai; Takuma Tsuzuku; Shoya Takahashi; Ayaka Okamoto; Takehisa Dewa; Mamoru Nango; Kenji Hyodo; Hiroshi Ishihara; Hiroshi Kikuchi; Naoto Oku
Journal:  Biochem Biophys Res Commun       Date:  2014-01-31       Impact factor: 3.575

Review 9.  Nanotechnology Approaches for the Delivery of Exogenous siRNA for HIV Therapy.

Authors:  Simeon K Adesina; Emmanuel O Akala
Journal:  Mol Pharm       Date:  2015-11-09       Impact factor: 4.939

Review 10.  Applications of RNA interference: current state and prospects for siRNA-based strategies in vivo.

Authors:  Achim Aigner
Journal:  Appl Microbiol Biotechnol       Date:  2007-04-25       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.